Axsome Therapeutics Inc. (AXSM) NASDAQ

$31.13 -2.45 (-7.30%)

Market Cap: $1.31B

As of 05/18/22 04:00 PM EDT. Market closed.

(AXSM)

Axsome Therapeutics Inc. (AXSM) NASDAQ

$31.13 -2.45 (-7.30%)

Market Cap: $1.31B

As of 05/18/22 04:00 PM EDT. Market closed.

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options. For the many people facing unsatisfactory treatments for CNS disorders, Axsome accelerates the invention and adoption of life-changing medicines. Axsome's core CNS product candidate portfolio includes five ... read more

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options. For the many people facing unsatisfactory treatments for CNS disorders, Axsome accelerates the invention and adoption of life-changing medicines. Axsome's core CNS product candidate portfolio includes five clinical-stage candidates, AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14. AXS-05 is being developed for major depressive disorder (MDD), Alzheimer's disease (AD) agitation, and as a treatment for smoking cessation. AXS-07 is being developed for the acute treatment of migraine. AXS-12 is being developed for the treatment of narcolepsy. AXS-14 is being developed for fibromyalgia. AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14 are investigational drug products not approved by the FDA. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Herriot Tabuteau
Full Time Employees
60
URL
Address
22 Cortlandt Street, 16Th Floor, New York, New York, 10007.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Herriot Tabuteau
Full Time Employees
60
CEO Compensation (Base)
$435,000
Address
22 Cortlandt Street, 16Th Floor, New York, New York, 10007.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$32.12
Previous Close
$33.58
Days Range
$30.53 - $33.64
52 week range
$19.38 - $74.10
Volume
665,204
Avg. Volume (30 days)
1,739,140
Market Cap
$1.31B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,913,550
Open
$32.12
Previous Close
$33.58
Days Range
$30.53 - $33.64
52 week range
$19.38 - $74.10
Volume
665,204
Avg. Volume (30 days)
1,739,140
Market Cap
$1.31B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,913,550

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AXSOME THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Coleman Mark Director Mar 15, 2022 Option Exercise $1.30 3,496 4,545 7,596 Mar 17, 2022, 07:05 AM
JEFFS ROGER Director Nov 19, 2021 Buy $37.30 3,950 147,350 120,756 Nov 23, 2021, 07:30 AM
Pizzie Nick CHIEF FINANCIAL OFFICER Nov 18, 2021 Buy $35.50 527 18,709 41,789 Nov 22, 2021, 07:31 AM
Pizzie Nick CHIEF FINANCIAL OFFICER Nov 18, 2021 Buy $34.97 428 14,968 201 Nov 22, 2021, 07:31 AM
Coleman Mark Director Nov 18, 2021 Buy $35.09 1,430 50,181 422,428 Nov 22, 2021, 07:30 AM
Saad Mark E Director Nov 17, 2021 Buy $34.42 300 10,325 100 Nov 19, 2021, 07:30 AM
Saad Mark E Director Nov 17, 2021 Buy $34.53 3,000 103,597 10,002 Nov 19, 2021, 07:30 AM
Coleman Mark Director May 12, 2021 Buy $58.15 500 29,075 420,998 May 13, 2021, 07:05 AM
Coleman Mark Director Jun 29, 2020 Buy $78.50 650 51,025 403,698 Jun 30, 2020, 08:20 AM
Pizzie Nick Chief Financial Officer Jun 29, 2020 Buy $76.64 777 59,549 41,217 Jun 30, 2020, 08:19 AM
JEFFS ROGER Director Jan 10, 2020 Option Exercise $10.46 60,186 629,756 116,806 Jan 14, 2020, 04:08 PM
Pizzie Nick Chief Financial Officer Sep 26, 2019 Buy $24.80 2,180 54,064 40,440 Sep 30, 2019, 07:16 AM
JEFFS ROGER Director Jul 03, 2019 Option Exercise $3.04 56,620 172,178 56,620 Jul 05, 2019, 07:00 AM
Coleman Mark Director Jun 26, 2019 Buy $23.10 15,800 364,980 668,848 Jun 27, 2019, 07:18 AM
Coleman Mark Director Jun 25, 2019 Buy $23.25 400 9,300 653,048 Jun 27, 2019, 07:18 AM
Pizzie Nick Chief Financial Officer Jun 11, 2019 Buy $20.80 1,920 39,936 1,920 Jun 12, 2019, 07:00 AM
Saad Mark E Director May 23, 2019 Buy $22.33 3,500 78,155 7,002 May 24, 2019, 07:19 AM
Coleman Mark Director May 13, 2019 Buy $21.44 4,650 99,696 652,648 May 15, 2019, 07:21 AM
Pizzie Nick Chief Financial Officer Mar 19, 2019 Buy $12.69 60 761 60 Mar 21, 2019, 07:05 AM
Pizzie Nick Chief Financial Officer Mar 19, 2019 Buy $12.58 5,340 67,177 36,340 Mar 21, 2019, 07:05 AM
Coleman Mark Director Mar 19, 2019 Buy $12.18 5,100 62,118 5,100 Mar 21, 2019, 07:05 AM
Pizzie Nick Chief Financial Officer Jun 19, 2018 Buy $3.10 31,000 96,080 31,000 Jun 20, 2018, 05:00 PM
JEFFS ROGER Director Mar 29, 2017 Option Exercise $4.73 42,538 201,163 46,912 Mar 30, 2017, 04:31 PM
Kaye Randall Chief Medical Officer Dec 23, 2015 Buy $9.03 1,000 9,026 6,022 Dec 24, 2015, 01:02 PM
Ames Constance Vice President, Finance Nov 24, 2015 Option Exercise $5.94 4,358 25,887 4,358 Nov 24, 2015, 04:26 PM
Kaye Randall Chief Medical Officer Nov 24, 2015 Option Exercise $5.40 5,022 27,119 5,022 Nov 24, 2015, 04:26 PM
Coleman Mark Director Nov 24, 2015 Option Exercise $5.71 564,948 3,224,166 647,998 Nov 24, 2015, 04:25 PM
JEFFS ROGER Director Nov 24, 2015 Option Exercise $5.94 4,374 25,982 4,374 Nov 24, 2015, 04:25 PM
Saad Mark E Director Nov 24, 2015 Option Exercise $5.94 3,502 20,802 3,502 Nov 24, 2015, 04:24 PM
TABUTEAU HERRIOT Chief Executive Officer Nov 24, 2015 Option Exercise $5.94 7,229 42,940 7,229 Nov 24, 2015, 04:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Coleman Mark Director 03/15/2022 4,545
JEFFS ROGER Director 11/19/2021 147,350
Pizzie Nick CHIEF FINANCIAL OFFICER 11/18/2021 18,709
Pizzie Nick CHIEF FINANCIAL OFFICER 11/18/2021 14,968
Coleman Mark Director 11/18/2021 50,181
Saad Mark E Director 11/17/2021 10,325
Saad Mark E Director 11/17/2021 103,597
Coleman Mark Director 05/12/2021 29,075
Coleman Mark Director 06/29/2020 51,025
Pizzie Nick Chief Financial Officer 06/29/2020 59,549
JEFFS ROGER Director 01/10/2020 629,756
Pizzie Nick Chief Financial Officer 09/26/2019 54,064
JEFFS ROGER Director 07/03/2019 172,178
Coleman Mark Director 06/26/2019 364,980
Coleman Mark Director 06/25/2019 9,300
Pizzie Nick Chief Financial Officer 06/11/2019 39,936
Saad Mark E Director 05/23/2019 78,155
Coleman Mark Director 05/13/2019 99,696
Pizzie Nick Chief Financial Officer 03/19/2019 761
Pizzie Nick Chief Financial Officer 03/19/2019 67,177
Coleman Mark Director 03/19/2019 62,118
Pizzie Nick Chief Financial Officer 06/19/2018 96,080
JEFFS ROGER Director 03/29/2017 201,163
Kaye Randall Chief Medical Officer 12/23/2015 9,026
Ames Constance Vice President, Finance 11/24/2015 25,887
Kaye Randall Chief Medical Officer 11/24/2015 27,119
Coleman Mark Director 11/24/2015 3,224,166
JEFFS ROGER Director 11/24/2015 25,982
Saad Mark E Director 11/24/2015 20,802
TABUTEAU HERRIOT Chief Executive Officer 11/24/2015 42,940
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
12/31/2021
1.87%
1Q
03/31/2022
09/30/2021
2.01%
2Q
03/31/2022
06/30/2021
2.16%
3Q
03/31/2022
03/31/2021
2.39%
4Q
03/31/2022
12/31/2020
3.00%
5Q
03/31/2022
12/31/2019
12.65%
9Q
03/31/2022
09/30/2019
13.48%
10Q
03/31/2022
06/30/2019
14.64%
11Q
03/31/2022
03/31/2019
15.95%
12Q
03/31/2022
12/31/2018
42.55%
13Q
03/31/2022
09/30/2018
48.10%
14Q
03/31/2022
06/30/2018
49.43%
15Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
1.87%
1Q
09/30/2021
2.01%
2Q
06/30/2021
2.16%
3Q
03/31/2021
2.39%
4Q
12/31/2020
3.00%
5Q
12/31/2019
12.65%
9Q
09/30/2019
13.48%
10Q
06/30/2019
14.64%
11Q
03/31/2019
15.95%
12Q
12/31/2018
42.55%
13Q
09/30/2018
48.10%
14Q
06/30/2018
49.43%
15Q
Load More